To be able to gauge the impact of APLP2′s presence in the pancreas on the progression of pancreatic cancer, we also employed in this current study a KPC mouse model with/without expression of the Aplp2 gene in the pancreas (i.e., conditional, pancreas-specific knockdown of APLP2). The gene discussed is APLP2; the disease is familial pancreatic carcinoma.